Back to Companies
SUPERNUS PHARMACEUTICALS, INC.
SUPNNasdaqCIK: 0001356576
Recent Form 4 activity at SUPERNUS PHARMACEUTICALS, INC. (SUPN) spans 50 filings across 11 insiders (all of them on the sell side). Purchases total $0 against $16.3M in sales — heavily weighted toward selling, for net sales of $16.3M. Khattar Jack A. (President, CEO, Director) is the most active by dollar volume, and the single largest transaction was $17.1M by Khattar Jack A.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$56.7M
Purchases
$0
Sales
$16.3M
Unique Insiders
11
Recent Insider Trades
50 loaded
| Jul 31 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Award | $0 |
| Jul 31 | SUPN SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | Award | $0 |
| Jul 31 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Award | $0 |
| Jul 31 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Award | $0 |
| Jul 31 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Award | $0 |
| Mar 10 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Horich William Todd | SVP, Commercial Operations | Other | $0 |
| Mar 3 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Award | $0 |
| Feb 25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Barlow Carrolee | Director | Grant | $0 |
| Feb 25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Director | Grant | $0 |
| Feb 25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Grant | $0 |
| Feb 25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Grant | $80.7K |
| Feb 25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Grant | $49.7K |
| Feb 25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | Grant | $120.8K |
| Feb 23 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sensenig Bethany | Director | Sell | $228.3K |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Award | $249.8K |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Award | $17.1M |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Barlow Carrolee | Director | Award | $249.8K |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Award | $677.7K |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | Award | $878.5K |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Award | $677.7K |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Director | Award | $249.8K |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Award | $677.7K |
| Jan 12 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Director | Exercise | $389.4K |
| Dec 22 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | $1.0M |
| Dec 19 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | $31.6K |
| Nov 24 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Exercise | $389.4K |
| Nov 17 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Award | $0 |
| Oct 10 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $3.0M |
| Oct 10 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Sell | $1.3M |
| Oct 3 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $91.5K |
| Oct 3 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Exercise | $708.2K |
| Oct 2 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $1.9M |
| Oct 1 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $414.4K |
| Sep 30 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $491.5K |
| Sep 26 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Exercise | $38.8K |
| Sep 24 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $1.4M |
| Sep 23 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $779.9K |
| Sep 15 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | $229.3K |
| Sep 12 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Award | $0 |
| Sep 12 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Award | $0 |
| Sep 9 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $292.6K |
| Sep 8 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $2.6M |
| Aug 29 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Sell | $161.5K |
| Aug 29 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $1.6M |
| Aug 27 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Sell | $45.0K |
| Aug 27 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $45.0K |
| Aug 27 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Exercise | $24.1K |
| Aug 27 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | $623.1K |
| Aug 26 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Sell | $63.5K |
| Aug 26 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO, Director | Sell | $67.5K |
50 filings+